When was SUDEEP PHARMA LIMITED incorporated?

SUDEEP PHARMA LIMITED was incorporated on Dec 21, 1989. It is registered with the Registrar of Companies, Ahmedabad, and its current company status is Active.

What is the Corporate Identification Number (CIN) of SUDEEP PHARMA LIMITED?

SUDEEP PHARMA LIMITED's Corporate Identification Number (CIN) is L24231GJ1989PLC013141.

What is the latest revenue of SUDEEP PHARMA LIMITED?

SUDEEP PHARMA LIMITED generated between ₹500 Cr and ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2025, reflecting a 1-year revenue CAGR of 10% and an EBITDA CAGR of 6%. The company is currently audited by Shah Mehta & Bakshi.

What is the registered address of SUDEEP PHARMA LIMITED?

The registered address of SUDEEP PHARMA LIMITED is 129/1/A, G.I.D.C. ESTATE NANDESARI, BARODA, Gujarat, India, 391340.

What is the latest employee count at SUDEEP PHARMA LIMITED?

As of Aug 01, 2025, the latest employee count at SUDEEP PHARMA LIMITED is 477, reflecting a 9% year-over-year growth in headcount.

Does SUDEEP PHARMA LIMITED have any loans on it?

SUDEEP PHARMA LIMITED has taken out 17 loans from the financial institutions KOTAK MAHINDRA BANK LIMITED, CITI BANK N.A. and THE BANK OF BARODA LIMITED, with a total disclosed borrowing of over ₹228Cr. The largest loan was ₹75Cr from KOTAK MAHINDRA BANK LIMITED in Dec 2024, followed by others ranging from ₹2.8L to ₹60.7Cr between Apr 1990 and Dec 2024.

Who are the authorized signatories of SUDEEP PHARMA LIMITED?

As of Sep 2026, the authorized signatories of SUDEEP PHARMA LIMITED include Sujit Jaysukh Bhayani, Shanil Sujit Bhayani and Sujit Gulati.

SUDEEP PHARMA LIMITED - 2026 Company Profile, Financials & Shareholding

Name: SUDEEP PHARMA LIMITED
Brand: SUDEEP PHARMA LIMITED
Price: 3.38 USD

SUDEEP PHARMA LIMITED is a Public Limited Company and was incorporated on Dec 21, 1989 in India. It is registered at Registrar of Companies, ROC Ahmedabad. Its registered address is 129/1/A, G.I.D.C. ESTATE NANDESARI, BARODA, Gujarat, India, 391340. Its corporate identification number is (CIN) L24231GJ1989PLC013141 and its current status is Active. Its industry classification as per MCA is manufacture Of Chemical Substances Used In The Manufacture Of Pharmaceuticals: Antibiotics, Endocrine Products, Basic Vitamins; Opium Derivatives; Sulpha Drugs;Serums And Plasmas; Salicylic Acid, Its Salts And Esters; Glycosides And Vegetable Alkaloids; Chemically Pure Sugar Etc. It had a team size of 477 employees as on Aug 01, 2025.

SUDEEP PHARMA LIMITED's last Annual General Meeting (AGM) was held on Aug 28, 2025 as per records from Ministry of Corporate Affairs (MCA). SUDEEP PHARMA LIMITED's authorised share capital is ₹15Cr and its paid up capital is ₹11.3Cr. The current board of directors of SUDEEP PHARMA LIMITED comprises Sujit Jaysukh Bhayani, Shanil Sujit Bhayani and 5 more.

SUDEEP PHARMA LIMITED generated between ₹500 Cr and ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2025.

Key Metrics

CIN

L24231GJ1989PLC013141

Location

India

Current Status

Active

Entity Type

Public Limited Company

Date Of Incorporation

Dec 21, 1989

Company Age

36 Years 9 Months

Registrar of Companies

ROC - Ahmedabad

Last AGM Date

Aug 28, 2025

Latest Revenue

₹500 - ₹1,000 Cr as on Mar 31, 2025

Latest Employee Count

477 as on Aug 01, 2025

Authorized Capital

₹15Cr

Paid Up Capital

₹11.3Cr

Email: *****@sudeepgroup.com, *****@sudeepgroup.com
Registered Address: 129/1/A, G.I.D.C. ESTATE NANDESARI, BARODA, Gujarat, India, 391340

There are 3 brands associated with SUDEEP PHARMA LIMITED which includes Sudeep Pharma , Sudeep Nutrition and Sudeep Group .

Name	Short Description	Founded Year	Location	Current Stage
Sudeep Pharma	Manufacturer of mineral based excipients and functional food ingredient additives	1989	India	Public
Sudeep Nutrition	Offering customized premixes and scientifically proven ingredients for various food and dietary supplement products	2021	India	Unfunded
Sudeep Group	Manufacturer and exporter of pharmaceutical, food, and animal feed ingredients	1989	India	Unfunded

View more details on SUDEEP PHARMA LIMITED's profile

The majority of SUDEEP PHARMA LIMITED's turnover comes from Manufacturing.

Main Activity Group Code	Description of Main Activity	Business Activity Code	Description of Business Activity	Turnover Percentage
C	Manufacturing	20	Manufacture of chemicals and chemical products	lwq

Here is the list of auditors of SUDEEP PHARMA LIMITED:

Name	Status	Appointment Date	Cessation Date
Shah Mehta & Bakshi	fcgenzh	od{mulw	pk{soqt

Filing Summary

Here is a summary of filing activity and document availability across financial years:

File Type	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Financial Statements			-
Annual Returns

Latest Financials, Share Allotment and Annual Report

The latest filed financial documents, annual reports, and share allotment filings are shown below:

Changes to Capital Structure

Buy Now

Recent Filings

Below are the most recent filings submitted by the company:

Document Name	Category	Filing Date
Form MSME	Other eForm Documents	Apr 30, 2026
Form BEN - 2	Other eForm Documents	Jan 03, 2026
List of Allottees	Other eForm Documents	Dec 01, 2025
Optional attachment(s)- if any	Other eForm Documents	Dec 01, 2025
Optional attachment(s)- if any	Other eForm Documents	Dec 01, 2025
Optional attachment(s)- if any	Other eForm Documents	Dec 01, 2025
Form PAS-3	Other eForm Documents	Dec 01, 2025
Optional attachment(s)- if any	Other eForm Documents	Dec 01, 2025
Optional attachment(s)- if any	Other eForm Documents	Dec 01, 2025
Optional attachment(s)- if any	Other eForm Documents	Nov 25, 2025

To access all company documents and filings with a single purchase, Buy Financials and Company Filings FY 25 Available15 mins

SUDEEP PHARMA LIMITED generated between ₹500 Cr and ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of SUDEEP PHARMA LIMITED has a compounded annual growth rate (CAGR) of 10% in the last 1 year.

Financial Statement Summary

Metrics	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Income Statement
Revenue	1213	3209	5274	1220	2379
Total Sales	9769	4517	9582	9068	3824
Total Expenses	6974	8727	4117	2961	2641
Operating Expenses	1673	3221	9376	5865	1783
Employee Expenses	5688	3552	1349	3747	1392
Marketing Expenses	8034	2225	8061	8120	7303
Operating Income (EBIT)	8159	4411	7599	9528	1838
Interest Expenses	5954	1785	2104	6291	3094
Expenses from other activities	8180	4150	1610	9201	9964
EBITDA	5261	1276	7385	6205	7428
Taxes	2323	3830	8941	4412	4493
Net Profit	4884	4715	3101	5589	8973
Balance Sheet
Assets	1571	7179	3556	3592	4616
Cash Equivalent	1944	8591	7975	3085	8194
Accounts Receivables	6242	7264	8891	2105	7896
Inventory	2556	3060	8724	7115	5697
Liabilities	7596	3749	6753	8160	7564
Total Debt	3914	2129	6640	2812	3412
Accounts Payable	9453	2060	4880	5346	3505
Equities	5768	8659	8696	3429	8654
Cashflow Statement
Cash from Operating activities	1866	8883	6332	6109	1841
Cash from Investing activities	2176	4293	2090	3073	4563
Net cash from Financing activities	3907	8950	2127	4922	3324

To access detailed financial performance and data, Buy Financial Report FY 25 Available

Ratios

Metrics	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Profitability Ratios
EBITDA Margin	2866	4306	6950	6169	3678
EBIT Margin	3091	6997	4580	4456	6136
Net Profit Margin	7329	5322	2004	9842	3411
Return on Assets (ROA)	4219	7851	3320	3464	2552
Return on Equity (ROE)	1792	2063	2376	2286	3379
Return on Capital Employed	3127	6704	9193	4991	6401
Return on Invested Capital	2485	1285	5926	6671	3837
Efficiency Ratios
Asset Turnover	6648	1046	4742	3279	6659
Receivables Turnover	3625	6414	9154	3137	1211
Days Sales Outstanding	2219	2909	9296	1848	7489
Inventory Turnover	2968	1288	3594	5966	9073
Days Inventory Outstanding	7652	5196	4823	5875	4048
Payables Turnover	6221	3803	9288	7867	1060
Days Payables Outstanding	7959	8440	4854	4156	5395
Liquidity Ratios
Current Ratio	6078	8587	6000	7507	7224
Quick Ratio	6556	3185	6133	7561	2639
Cash Ratio	9386	7328	1238	2439	6885
Coverage Ratios
Cash Flow Coverage Ratio	4626	6665	1265	2907	1678
Debt Ratios
Debt-to-Equity Ratio	4809	3154	7138	6746	1295
Debt Ratio	3370	8764	6439	3873	3478
Net Debt	5291	5479	7433	4118	7004
Interest Coverage Ratio	3890	5700	3533	6808	9454
Debt Service Coverage Ratio	6786	4573	2478	6806	7193
Net Debt/EBITDA	4617	6198	3913	2033	9688
Growth Ratios
Revenue Growth Rate (CAGR)	3516	4443	7565	2568	8827
Earnings Growth Rate (CAGR)	6496	4248	9748	7423	9675

To access detailed financial performance and data, Buy Financial Report FY 25 Available

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Compounded Annual Growth Rate of SUDEEP PHARMA LIMITED

Revenue CAGR	Growth
1 Year	10%
3 Year	133
5 Year	332

EBITDA CAGR	Growth
1 Year	6%
3 Year	588
5 Year	189

Disclaimer

There are 17 delayed MSME payments recorded for SUDEEP PHARMA LIMITED during Oct 2025 - Mar 2026.

Here are the details of MSME payment delays for this period:

Supplier Name	Supplier PAN	Amount Due	Due since
VEER CONVERTER	5856	1901	6665
DIVIS PHARMACHEM	3882	5364	9211
RIDDHI SIDDHI CHEM	4367	7154	9848
DEVAL POLYMERS	5742	8896	7960
Wellmix Agitech	2420	1761	5770
RAYRHYT HMS Industrie s Pvt Ltd	1266	2733	5721
SVSM PACKAGI NG PRIVATE LIMITED	2296	5641	1075
PLASTOCLUE INDUSTRIES	2266	5565	7652
RATKIL FACILITYSERVICES	2508	4283	4679
SHREEJI INDUSTR IES	7163	5715	5376

To access detailed supplier-wise and period-wise MSME payment delay information,

SUDEEP PHARMA LIMITED has taken 17 loans.

Here is a list of loans and charges on SUDEEP PHARMA LIMITED:

As a Borrower

Loan/ Charge ID	Lender Name	Loan Amount	Status	Creation Date	Closure Date
101026268	KOTAK MAHINDRA BANK LIMITED	₹75Cr	hwieibx	Dec 30, 2024	baebnji
100539717	KOTAK MAHINDRA BANK LIMITED	₹60.7Cr	{cpgaij	Jan 29, 2022	aosdqbp
100376016	-	₹20Cr	rdmr{cv	Sep 29, 2020	kucuaph
100289600	-	₹6.5Cr	nsdioec	Aug 20, 2019	kzvwjqf
10475518	-	₹45Cr	ymwwffu	Jan 27, 2014	qnszkvf
10465390	THE BANK OF BARODA LIMITED	₹6.23L	xurncik	Nov 02, 2013	nenxhce
10245345	THE BANK OF BARODA LIMITED	₹38.6L	lbobvdy	Sep 21, 2010	vhdgdxy
10100035	THE BANK OF BARODA LIMITED	₹50L	zuaijan	Mar 13, 2008	pmcfcwv
90105283	THE BANK OF BARODA LIMITED	₹5.51L	mpjtqx{	Oct 10, 2003	frxfefo
90104914	THE BANK OF BARODA LIMITED	₹4.43L	srqcj{p	Nov 30, 1999	ishagvg
90106218	THE BANK OF BARODA LIMITED	₹8.14Cr	carkoit	Aug 12, 1996	qslnxbz
90104654	THE BANK OF BARODA LIMITED	₹75.8L	lavycv{	Aug 12, 1996	gyg{ils
90104579	THE BANK OF BARODA LIMITED	₹2.8L	zkmnyvq	Nov 14, 1994	misheai
90103900	THE BANK OF BARODA LIMITED	₹10.6Cr	erxzaoc	Aug 17, 1990	xgezkja
90105601	THE BANK OF BARODA LIMITED	₹29.8L	{lqbsqb	Apr 05, 1990	nbphspr
90106072	THE BANK OF BARODA LIMITED	₹26L	ioa{iea	Apr 05, 1990	bzselxm
90104449	THE BANK OF BARODA LIMITED	₹11L	qmlzrfe	Apr 05, 1990	gpdelta

To access detailed information on a company’s loans, borrowings, & registered charges,

Founders (largest shareholder) own 47.80%, Funds own 9.77%, Angels own 0.39% and Parent Entities own 40.14%. The net worth of SUDEEP PHARMA LIMITED's founders is INR 3,050Cr as of May 15, 2025.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	47.80%	3,050Cr	4479298	2642622	2529252	2076856
Avani Bhayani	5045680	7649471	1776911	3743455	7302502	5117888
Sujit Bhayani	7407447	8705313	8451801	4549846	5963245	7351510
Shanil Sujit Bhayani	80676	86299	74586	99698	88052	53144
Fund	9.77%	623Cr	8828982	6882330	9994565	5779938
Nuvama	5277872	1271978	3545620	2319098	5823813	5321193
White Oak	0	0	0	0	0	0
Dalmia Family Office Trust	0	0	0	0	0	0
Angel	0.39%	25Cr	0	0	0	0
Mukul Agrawal	0	0	0	0	0	0
Parent Entity	40.14%	2,560Cr	4132937	1480118	2481271	5243342
ESOP Pool	1.91%	122Cr	7	4	7	8
Total	100.00%	6,380Cr	9003899	1489937	5690154	2324806

To access the complete ownership breakdown, Buy Cap Tables

Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.

Board of Directors of SUDEEP PHARMA LIMITED

Here is the list of current board of directors of SUDEEP PHARMA LIMITED:

Name	Designation	Status	Appointment Date	Duration
Sujit Jaysukh Bhayani	Managing Director	Current	Oct 26, 2015	10 Years 11 Months
Shanil Sujit Bhayani	Whole-time Director	Current	Dec 10, 2021	4 Years 9 Months
Sujit Gulati	Director	Current	Sep 19, 2024	2 Years
Reshma Suresh Patel	Director	Current	Sep 25, 2024	2 Years
Ajay Shrirang Kandelkar	Whole-time Director	Current	Sep 26, 2024	2 Years
Samaresh Parida	Director	Current	Oct 04, 2024	1 Year 11 Months
Raghunandan Sathyanarayan Rao	Director	Current	Oct 10, 2024	1 Year 11 Months

To access detailed information on a company’s board members, directors, & authorized signatories,

Signatories of SUDEEP PHARMA LIMITED

Here is the list of current signatories of SUDEEP PHARMA LIMITED:

Name	Designation(s)	Status	Appointment Date	Duration
Sujit Jaysukh Bhayani	Managing Director	Current	Oct 26, 2015	10 Years 11 Months
Shanil Sujit Bhayani	Whole-time Director	Current	Dec 10, 2021	4 Years 9 Months
Sujit Gulati	Director	Current	Sep 19, 2024	2 Years
Reshma Suresh Patel	Director	Current	Sep 25, 2024	2 Years
Ketan Jagdishchandra Vyas	CFO	Current	Sep 26, 2024	2 Years
Ajay Shrirang Kandelkar	Whole-time Director	Current	Sep 26, 2024	2 Years
Samaresh Parida	Director	Current	Oct 04, 2024	1 Year 11 Months
Raghunandan Sathyanarayan Rao	Director	Current	Oct 10, 2024	1 Year 11 Months
Dimple Ashwinbhai Mehta	Company Secretary	Current	Dec 13, 2024	1 Year 9 Months

To access detailed information on a company’s board members, directors, & authorized signatories,

Cross Directorships of SUDEEP PHARMA LIMITED

SUDEEP PHARMA LIMITED has directors who also hold positions in 22 other legal entities. The top 20 are listed below:

Legal Entity Name	% of Common Directors	Common Director(s)	Open Charge(s)	Active Legal Case(s)
SUDEEP NUTRITION PRIVATE LIMITED CIN: U24304GJ2020PTC116505, India, Active	385	131	236	616
ALTMIN PRIVATE LIMITED CIN: U13209TG2023PTC170229, India, Active	406	177	889	232
SUDEEP ADVANCED MATERIALS PRIVATE LIMITED CIN: U27201GJ2024PTC154625, India, Active	797	800	382	108
RIVA RESOURCES PRIVATE LIMITED CIN: U46909GJ2024PTC147628, India, Active	430	489	483	523
SOUTHERN HEALTH FOODS PRIVATE LIMITED CIN: U15499TN2012PTC085450, India, Active	990	968	314	526
MATRIX COMSEC PRIVATE LIMITED CIN: U72200GJ1998PTC034047, India, Active	695	127	548	273
IDBI BANK LIMITED CIN: L65190MH2004GOI148838, India, Active	424	268	769	845
TIIVRA VENTURES PRIVATE LIMITED CIN: U50404MH2020PTC339911, India, Active	150	209	393	729
SHRI DINESH MILLS LIMITED CIN: L17110GJ1935PLC000494, India, Active	104	487	564	900
SHAILY ENGINEERING PLASTICS LIMITED CIN: L51900GJ1980PLC065554, India, Active	357	957	734	578
GOKUL AGRO RESOURCES LIMITED CIN: L15142GJ2014PLC080010, India, Active	732	877	177	924
GUJARAT AROGYA SEVA PRIVATE LIMITED CIN: U74999GJ2017PTC096542, India, Dissolved (Liquidated)	251	138	580	632
VASUTA ACCELINVEST AND MANAGEMENT ADVISORS PRIVATE LIMITED CIN: U74999GJ2020PTC113232, India, Active	896	734	653	942
SHRENO PUBLICATIONS LIMITED CIN: U75302GJ2004PLC044463, India, Active	864	951	108	382
CAPACITOR SPECIALISTS PRIVATE LIMITED CIN: U33121GJ1979PTC003433, India, Amalgamated	148	156	962	389
NUSHI ENTERPRISES PRIVATE LIMITED CIN: U36941GJ1991PTC016743, India, Active	108	300	951	282
ARMEE INFOTECH LIMITED CIN: U72100GJ2011PLC063953, India, Active	240	505	786	516
SML DIGITAL MEDIA PRIVATE LIMITED CIN: U72900GJ2022PTC135800, India, Active	430	395	167	904
IDBI BANK LIMITED CIN: L65190MH2004GOI148838, India, Active	521	270	591	496
HKRP INNOVATIONS LIMITED CIN: U35100GJ2024PLC153604, India, Active	698	369	633	452

To access detailed information on a company’s board members, directors, & authorized signatories,

SUDEEP PHARMA LIMITED has an employee count of 477 as on Aug 01, 2025.

Employee count trend for SUDEEP PHARMA LIMITED

Date	Employee Count
Aug 25	477
Jul 25	918
Jun 25	127
May 25	916
Apr 25	375
Mar 25	926
Feb 25	383

There are 3 brands associated with SUDEEP PHARMA LIMITED, including Sudeep Pharma, Sudeep Nutrition, and others. Here is the list of the Top 10 competitors of Sudeep Pharma ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Colorcon 1961, Harleysville (United States), Acquired	Developer of specialty excipients and corporate-backed venture capital fund focused on healthcare startups	-	-	63/100
2nd	Sudeep Pharma 1989, Vadodara (India), Public	Manufacturer of mineral based excipients and functional food ingredient additives	$18.7M	White Oak, Dalmia Family Office Trust & 3 others	59/100
3rd	DFE Pharma 2011, Goch (Germany), Acquired	Developer and manufacturer of excipients for oral solid dosage forms and dry powder inhalations	-	FrieslandCampina	47/100
4th	SPI Pharma 2000, Wilmington (United States), Funding Raised	Manufacturer of formulations and excipient products	-	Arrowhead Investment Management	41/100
5th	Pfanstiehl 1919, Waukegan (United States), Acquired	GMP injectable excipients for biopharmaceutical and vaccine stabilization, protection, and delivery	$6.7M	Fidus Investment	41/100
6th	Crest Cellulose 2011, Hyderabad (India), Acquired	Developer and manufacturer of pharmaceutical excipients and food ingredients	-	-	41/100
7th	Finar 1998, Ahmedabad (India), Acquired	Manufacturer of excipients, solvents, lab chemicals, food additives, and other fine chemicals	-	-	39/100
8th	Vikram Thermo 1984, Ahmedabad (India), Public	Manufacturer of excipients for small molecules	-	-	37/100
9th	Meggle Pharma 2005, Wasserburg Am Inn (Germany), Unfunded	Developer and manufacturer of pharmaceutical excipients	-	-	37/100
10th	JRS Pharma 1878, Baden Baden (Germany), Unfunded	Developer and manufacturer of excipients	-	-	37/100